aTyr Pharma Dirección
Dirección controles de criterios 3/4
El CEO de aTyr Pharma's es Sanjay Shukla , nombrado en Nov 2017, tiene una permanencia de 6.42 años. compensación anual total es $1.30M, compuesta por 43.2% salario y 56.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.17% de las acciones de la empresa, por valor de $186.47K. La antigüedad media del equipo directivo y de la junta directiva es de 5.5 años y 14.5 años, respectivamente.
Información clave
Sanjay Shukla
Chief Executive Officer (CEO)
US$1.3m
Compensación total
| Porcentaje del salario del CEO | 43.2% |
| Permanencia del CEO | 6.5yrs |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | 5.6yrs |
| Promedio de permanencia en la Junta Directiva | 14.6yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Hopeful That aTyr Pharma (NASDAQ:LIFE) Will Use Its Cash Wisely
Feb 03
Here's Why We're Not Too Worried About aTyr Pharma's (NASDAQ:LIFE) Cash Burn Situation
Oct 04Here's Why We're Watching aTyr Pharma's (NASDAQ:LIFE) Cash Burn Situation
May 06We're Keeping An Eye On aTyr Pharma's (NASDAQ:LIFE) Cash Burn Rate
Jan 04aTyr Pharma rises on U.S. patent for anti-neuropilin-2 monoclonal antibodies
Sep 29aTyr Pharma stock rises on FDA fast track status for efzofitimod for lung disease
Sep 13aTyr Pharma gains with FDA Fast Track status for lead asset
Aug 11We Think aTyr Pharma (NASDAQ:LIFE) Needs To Drive Business Growth Carefully
May 10Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?
Jan 24aTyr Pharma: Successful Proof Of Concept In Pulmonary Sarcoidosis
Dec 28aTyr Stock Is Buoyant On Highly-Promising Lung Disease Data - Wait For Hype To Die Down And Buy
Sep 24Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?
Sep 23Is aTyr Pharma (NASDAQ:LIFE) In A Good Position To Deliver On Growth Plans?
May 22aTyr Pharma, Inc. (NASDAQ:LIFE) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 25Did You Miss aTyr Pharma's (NASDAQ:LIFE) Impressive 103% Share Price Gain?
Feb 09
aTyr Pharma, Kyorin concludes subject visits for early-stage ATYR1923 trial in Japan
Jan 14ATyr Pharma's lead candidate meets safety endpoint in COVID-19 study
Jan 04aTyr Pharma concludes enrollment in mid-stage inflammatory lung diseases study
Dec 21aTyr Pharma (LIFE) Investor Presentation - Slideshow
Oct 31Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$54m |
| Dec 31 2023 | US$1m | US$561k | -US$50m |
| Sep 30 2023 | n/a | n/a | -US$43m |
| Jun 30 2023 | n/a | n/a | -US$45m |
| Mar 31 2023 | n/a | n/a | -US$45m |
| Dec 31 2022 | US$2m | US$561k | -US$45m |
| Sep 30 2022 | n/a | n/a | -US$46m |
| Jun 30 2022 | n/a | n/a | -US$41m |
| Mar 31 2022 | n/a | n/a | -US$39m |
| Dec 31 2021 | US$2m | US$510k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$30m |
| Jun 30 2021 | n/a | n/a | -US$29m |
| Mar 31 2021 | n/a | n/a | -US$25m |
| Dec 31 2020 | US$1m | US$470k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$17m |
| Jun 30 2020 | n/a | n/a | -US$16m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$664k | US$450k | -US$24m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$30m |
| Dec 31 2018 | US$1m | US$450k | -US$35m |
| Sep 30 2018 | n/a | n/a | -US$40m |
| Jun 30 2018 | n/a | n/a | -US$44m |
| Mar 31 2018 | n/a | n/a | -US$45m |
| Dec 31 2017 | US$2m | US$403k | -US$48m |
Compensación vs. Mercado: La compensación total de Sanjay($USD1.30M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).
Compensación vs. Ingresos: La compensación de Sanjay ha sido consistente con los resultados de la empresa en el último año.
CEO
Sanjay Shukla (51 yo)
6.5yrs
Permanencia
US$1,300,525
Compensación
Dr. Sanjay S. Shukla, M.D. M.S. has been the Chief Executive Officer, President and Director at aTyr Pharma, Inc. since November 1, 2017. Dr. Shukla served as Chief Medical Officer at aTyr Pharma, Inc. fro...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.5yrs | US$1.30m | 0.17% $ 198.1k | |
| Chief Financial Officer | 5.8yrs | US$677.84k | 0.031% $ 35.4k | |
| General Counsel & Corporate Secretary | 9.6yrs | US$651.28k | 0.022% $ 25.1k | |
| Founder | no data | sin datos | sin datos | |
| Director of Investor Relations & Corporate Communications | no data | sin datos | sin datos | |
| Vice President of Corporate Development | 4.3yrs | sin datos | sin datos | |
| VP of Human Resource | 2.4yrs | sin datos | sin datos | |
| Vice President of Research | no data | sin datos | sin datos | |
| Executive Director of Biologics Development & Manufacturing | no data | sin datos | sin datos | |
| Scientific Consultant | 5.4yrs | US$717.31k | sin datos |
5.6yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de LIFE es experimentado (5.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.5yrs | US$1.30m | 0.17% $ 198.1k | |
| Independent Director | 18.7yrs | US$120.84k | 0.029% $ 33.7k | |
| Independent Director | 18.7yrs | US$61.20k | 1.47% $ 1.7m | |
| Member of Scientific Advisory Board | 14.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 14.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Chairman of the Board | 7.1yrs | US$92.20k | 0.0088% $ 10.2k | |
| Member of Scientific Advisory Board | 14.7yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 4.8yrs | US$68.88k | 0.0088% $ 10.2k |
14.6yrs
Permanencia media
66yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de LIFE son experimentados ( 14.5 años antigüedad media).